The effect of α-blocker therapy on erectile functions in patients with lower urinary tract symptoms due to benign prostate hyperplasia
Authors:
- Omer DemirODOmer Demir
- Ismail OzdemirIOIsmail Ozdemir
- Ozan BozkurtOBOzan Bozkurt
- Guven AslanGAGuven Aslan
- Ahmet Adil EsenAEAhmet Adil Esen
Open Access
- 12 October 2009
- journal article
- research article
- Published by Medknow in Asian Journal of Andrology
- Vol. 11 (6) , 716-722
Abstract
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.Keywords
This publication has 27 references indexed in Scilit:
- Effects of phosphodiesterase type 5 inhibitor on the contractility of prostate tissues and urethral pressure responses in a rat model of benign prostate hyperplasiaInternational Journal of Urology, 2007
- Atherosclerosis as a risk factor for benign prostatic hyperplasiaBJU International, 2006
- Assessment of the Impact of Sildenafil Citrate on Lower Urinary Tract Symptoms in Men with Erectile DysfunctionThe Journal of Sexual Medicine, 2006
- Effect of Doxazosin With and Without Rho-Kinase Inhibitor on Human Corpus Cavernosum Smooth Muscle in the Presence of Bladder Outlet ObstructionJournal of Urology, 2006
- ASSOCIATION BETWEEN LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTIONArchives of Andrology, 2006
- Erectile Dysfunction and Lower Urinary Tract Symptoms Secondary to BPHEuropean Urology, 2005
- Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on α 1 ‐adrenoceptor antagonistsBJU International, 2005
- Erectile Dysfunction (ED) is Prevalent, Bothersome and Underdiagnosed in Patients Consulting Urologists for Benign Prostatic Syndrome (BPS)European Urology, 2005
- EFFECT OF DIABETES ON LOWER URINARY TRACT SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIAJournal of Urology, 2000
- Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 1998